Some patients with moderate to severe COVID-19 disease seem to experience inflammation of the thyroid gland that is different from thyroid inflammation caused by other viruses, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Tag: Endocrinology
Common drugs for type 2 diabetes and obesity do not increase breast cancer risk
Commonly used medications for type 2 diabetes and obesity called glucagon like peptide-1 receptor agonists (GLP-1 RAs), are not associated with an increased risk of breast cancer, despite previous studies that suggested a possible link, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Poor diabetes control in children tied to high risk for COVID-19 complications, death
Children with poorly controlled type 1 diabetes have a 10 times higher risk of COVID-19-related complications and death compared to those with well-controlled diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Hospitalized COVID-19 patients with obesity are significantly more likely to need ICU care
People with obesity who are hospitalized with COVID-19 have a significantly higher rate of ICU admissions and longer duration of ICU stay compared to people with a normal body mass index (BMI), according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Largest-ever analysis of its kind finds Cushing’s syndrome triples risk of death
Endogenous Cushing’s syndrome, a rare hormonal disorder, is associated with a threefold increase in death, primarily due to cardiovascular disease and infection, according to a study whose results will be presented at ENDO 2021, the Endocrine Society’s annual meeting.
Sleep disturbances may contribute to weight gain in menopause
Addressing sleep symptoms during menopause may reduce susceptibility to weight gain, according to a small study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Genetic evidence suggests men can develop PCOS-like condition
New genetic research suggests men can develop characteristics of polycystic ovary syndrome (PCOS)—a common metabolic and reproductive disorder that affects women. The study was presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Tubeless automated insulin delivery system improves blood glucose outcomes
People with type 1 diabetes can improve their blood sugar control while reducing time with low blood sugar, or hypoglycemia, using Insulet Corporation’s Omnipod 5 Automated Insulin Delivery System compared to their standard insulin therapy. Results from an industry-sponsored study of the latest Omnipod, the first tubeless, wearable insulin pump, will be presented at ENDO 2021, the Endocrine Society’s annual meeting.
First targeted therapy for children with achondroplasia shows persistent height gain for up to two years
Children with achondroplasia, the most common form of disproportionate short stature, grow taller with trends in improved body proportions after two years of daily vosoritide treatment, a new study analysis finds. Results of the industry-sponsored study will be presented at ENDO 2021, the Endocrine Society’s annual meeting.
Many endocrine patients, providers want to continue telehealth after pandemic
Two-thirds of patients with chronic endocrine health problems who need close monitoring say they would like to continue with telemedicine follow-up visits after the COVID-19 pandemic ends, according to a survey that will be presented virtually at ENDO 2021, the Endocrine Society’s annual meeting. Three-quarters of providers also said they want to continue with telehealth after the pandemic.
Study finds oral testosterone therapy undecanoate is effective, with no liver toxicity
An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with low testosterone levels, with no evidence of liver toxicity. The findings are being presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
“Hunger hormone” ghrelin affects monetary decision making
Higher levels of the stomach-derived hormone ghrelin, which stimulates appetite, predict a greater preference for smaller immediate monetary rewards over larger delayed financial rewards, a new study finds. The study results will be presented at ENDO 2021, the Endocrine Society’s annual meeting.
Combination thyroid hormone therapies treat hypothyroidism as well as levothyroxine
Treatment of hypothyroidism, which results from an underactive thyroid gland, should be individualized and consideration should be given to alternatives to the first-line therapy, including desiccated thyroid extract and combination therapy to replace the body’s two main thyroid hormones, thyroxine (T4) and triiodothyronine (T3). Results of their new randomized clinical study are being presented at ENDO 2021, the Endocrine Society’s annual meeting.
Increased risk of hearing impairment with new thyroid eye disease treatment
More patients than previously reported may experience hearing symptoms such as hearing loss or muffled hearing from a new treatment for thyroid eye disease, teprotumumab (Tepezza), according to a small study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
U.S. children from Spanish-speaking households experience higher rate of obesity than those from English-speaking families
Nearly one in five U.S. children and teenagers has obesity, and statistics show a higher prevalence of obesity in certain ethnicities, such as Hispanics and Blacks. Now results of a study being presented at ENDO 2021, the Endocrine Society’s annual meeting, suggest that Spanish as a family’s primary language is a predictor of childhood obesity, regardless of ethnicity.
Hospitalized COVID-19 patients fare worse when they have high blood sugar
Patients hospitalized with COVID-19 have worse outcomes if they have high blood sugar, or hyperglycemia, regardless of whether they have diabetes, a new study finds. The researchers will present their results, of the first known study of the impact of hyperglycemia on a largely Black patient population with the novel coronavirus, at ENDO 2021, the Endocrine Society’s annual meeting.
Semaglutide reduces excess body fat in people with obesity
In adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide leads to reduced excess body fat and increased lean body mass, according to an industry-sponsored study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Lifestyle program improves fertility for women with obesity, infertility
A lifestyle intervention targeting women with obesity and infertility is more effective in increasing the pregnancy rate compared with fertility treatments, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Black women with PCOS have higher risk factors for heart disease, diabetes and stroke
Black women with polycystic ovary syndrome (PCOS) have higher risk factors for heart disease, diabetes and stroke compared with white women, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Supplements may protect those with low vitamin D levels from severe COVID-19
Patients with low vitamin D levels who are hospitalized for COVID-19 may have a lower risk of dying or requiring mechanical ventilation if they receive vitamin D supplementation of at least 1,000 units weekly, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Few patients at risk for common high blood pressure disorder receive screening
Only 3% of patients at high risk for primary aldosteronism (PA), a common disorder that causes high blood pressure and can lead to heart and kidney complications, are screened for the condition, according to a study that will be presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Obesity raises type 2 diabetes risk in women with PCOS
Women with obesity and polycystic ovarian syndrome (PCOS) are at increased risk of developing type 2 diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting. Normal-weight women with PCOS are not at increased risk, the researchers found.
Transgender youth face higher risk of conditions that affect heart health
Transgender youth have higher odds than cisgender youth of being diagnosed with medical conditions that can affect their overall metabolic and cardiovascular health, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
White button mushrooms could slow progression of prostate cancer
The chemicals present in white button mushrooms may slow the progression of prostate cancer, according to a mouse study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Children, teens with type 1 diabetes had better glucose control during COVID-19 lockdown
Blood glucose levels improved among children and teens with type 1 diabetes during the first 12 weeks of COVID-19 lockdown in the United Kingdom, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
New treatment shows promise in preventing heart failure after heart attack
A study in mice finds treatment with a molecule called MCB-613 repairs heart tissue after a severe heart attack, preventing damage that can lead to heart failure. The findings are being presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Night owls with gestational diabetes may face higher risk of pregnancy complications
Among women who develop diabetes during pregnancy, night owls have a higher risk of complications for mother and baby than early birds do, according to a study whose results will be presented at ENDO 2021, the Endocrine Society’s annual meeting.
Children, teens with type 1 diabetes had better glucose control during COVID-19 lockdown
Study highlights challenges of managing disease with activities outside the home
Supplements may protect those with low vitamin D levels from severe COVID-19
Study finds more than half of patients with low vitamin D do not receive supplements
Children with adrenal insufficiency are 10 times more likely to die from COVID-19
Study shows importance of preventing, treating COVID-19 in children with adrenal condition
Semaglutide reduces excess body fat in people with obesity
Findings suggest drug has potential to reduce risk of heart disease, diabetes and stroke
Few patients at risk for common high blood pressure disorder receive screening
Primary aldosteronism screening important for preventing heart, kidney disease
Transgender youth face higher risk of conditions that affect heart health
Study finds increased odds of abnormal cholesterol levels, elevated body mass index, liver dysfunction and elevated blood pressure
Genetic evidence suggests men can develop PCOS-like condition
Study indicates PCOS may not be primarily a female reproductive disorder
White button mushrooms could slow progression of prostate cancer
Mouse study suggests mushrooms may suppress androgen receptor activity
Hospitalized COVID-19 patients with obesity are significantly more likely to need ICU care
Study did not find higher risk of death in people with obesity, COVID-19
Hospitalized COVID-19 patients fare worse when they have high blood sugar
High blood sugar linked to higher risk of death in patients with and without diabetes
‘Hunger hormone’ ghrelin affects monetary decision making
High ghrelin levels in healthy females predict more impulsive choices, researchers say
Spanish-speaking children experience higher rate of obesity than English-speaking children
Childhood obesity also more prevalent among U.S. households with low socioeconomic status
Largest-ever analysis of its kind finds Cushing’s syndrome triples risk of death
Heart disease and infections rank as top causes of death among those with rare disorder
Lifestyle program improves fertility for women with obesity, infertility
Intervention offers cost-effective alternative to standard of care for women with obesity
Many endocrine patients, providers want to continue telehealth after pandemic
Three in four patients say telehealth quality of care is similar to in-person visits
Night owls with gestational diabetes may face higher risk of pregnancy complications
Mothers who prefer evening activity also more likely to give birth to newborns requiring neonatal intensive care
New treatment shows promise in preventing heart failure after heart attack
Mouse study finds molecule repairs heart tissue to avoid damage
Black women with PCOS have higher risk factors for heart disease, diabetes and stroke
Findings highlight need to address health disparities in women with PCOS
Obesity raises type 2 diabetes risk in women with PCOS
Findings underscore importance of weight control in women with PCOS
COVID-19 can cause atypical thyroid inflammation
Study will follow patients to determine if inflammation causes long-term health effects
Poor diabetes control in children tied to high risk for COVID-19 complications, death
Findings can help families make decisions about in-person schooling
Common drugs for type 2 diabetes and obesity do not increase breast cancer risk
Findings relieve concerns arising from clinical trials of liraglutide
Sleep disturbances may contribute to weight gain in menopause
Study suggests addressing sleep problems could help women avoid middle age weight gain